Skip to content
Clinical Trials – home
Therapeutic area

Vascular disorders – page 42

  • 838 clinical trials
  • 353 recruiting
  • 378 conditions
  • 28 countries

Conditions in this area

378 conditions with trials, the busiest first

Clinical trials in Vascular disorders

838 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

838 clinical trials

Migraine

Not yet recruiting

Study on Atorvastatin for Preventing Chronic Migraine in Adults

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Migraine

Not yet recruiting

Study on Atorvastatin for Preventing Episodic Migraine in Adults

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Study on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Universitair Medisch Centrum Utrecht

Ischaemic stroke

Not yet recruiting

Study of ApTOLL for Treating Acute Ischemic Stroke in Patients Before Hospital Arrival

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Aptamer-4Ft
  • Sponsor:Aptatargets S.L.

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Diabetic foot

Not yet recruiting

Study Comparing Propylene Glycol and Urea Creams for Treating Dry Feet in People with Diabetes

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Propylene Glycol
  • Sponsor:Malmoe Universitet

Cerebral amyloid angiopathy

Not yet recruiting

Study on the Safety and Effects of Acetylcysteine Amide for Patients Aged 12 and Over with Hereditary Cystatin C Amyloid Angiopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Acetylcysteine Amide
  • Sponsor:Arctic Therapeutics ehf.

Study on Sildenafil and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Sildenafil
  • Sponsor:Assistance Publique Hopitaux De Paris

Thromboangiitis obliterans

Not yet recruiting

Study on Botulinum Toxin Type A for Treating Buerger's Disease in Patients Eligible for Injection Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Centre Hospitalier Universitaire De Toulouse

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Alexion Pharmaceuticals Inc.

Substances studied in this area

The therapies tested most often in Vascular disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.